Cilostazol Capsules

The mechanism of action of this product in improving intermittent thromboembolism symptoms is not yet fully understood. This product and its metabolites are cyclic adenosine monophosphate (cAMP) phosphodiesterase III inhibitors (PDEIII inhibitors), which can reduce the degradation of cAMP by inhibiting the activity of phosphodiesterase, thereby increasing the cAMP level in platelets and blood vessels, inhibiting platelet aggregation and vasodilation.

6-[4-(1-cyclohexyl-1H-pentyletetrazolium (5'))butoxy]-3,4-dihydro-1H-quinolone (2)

The content of this product is white granular powder.

Improve symptoms such as chronic ulcers, pain, chills and intermittent claudication caused by chronic arteriosclerosis obliterans.

Oral administration: 100 mg (two capsules) at a time, twice a day. The dosage can be increased or decreased according to the condition.

1 Systemic adverse reactions: abdominal pain, back pain, headache, infection, edema. 2 Circulatory system: occasional palpitations, rapid pulse, fever, dizziness, hypotension. 3 Digestive system: occasional stomach discomfort, upper abdominal pain, abdominal distension, loss of appetite, nausea, vomiting, soft stools, diarrhea. 4 Allergic reactions: occasional rash, eruptions, urticaria, itching. 5 Nervous system: occasional headache, heavy head, dizziness, vertigo, insomnia, numbness, occasional drowsiness, fatigue. 6 Liver: occasional increase in AST, ALT, LDH values. 7 Kidney: occasional increase in BUN, creatine, uric acid values

1. Patients who are allergic to any component of this drug. 2. Patients with grade 3-4 congestive heart failure. 3. Patients with bleeding such as hemophilia, capillary fragility, upper gastrointestinal bleeding, hemoptysis, etc. 4. Women who are pregnant or may become pregnant.

Precautions for children: The safety of the drug for infants and young children has not been established. Precautions for pregnancy and lactation: Women who are pregnant or may become pregnant. Precautions for the elderly: Not yet clear.

Prostaglandin E1 works synergistically with this product to increase intracellular cyclic guanosine-phosphate and enhance therapeutic efficacy.

Store in a sealed container at room temperature. The validity period is tentatively set at two years.

50mg

36 months

Yantai Valiant Pharmaceutical Co., Ltd.

• Founded in:

  2012-02-08

• Address:

  No. 60, Taiyuan Road, Dajijia Industrial Park, Yantai Development Zone

• Tax NO.:

  91370600590337681X

• Registered Funds:

  75 million yuan

• Website:

  Log in to view

• Email:

  Log in to view